- Home
- Clinical Trials
COVID-19 Study Brisbane TA 83
COVID-19 Study
Tested positive for COVID-19 in the last 5 days?
You may be eligible to join a clinical research study evaluating a potential new antiviral treatment for COVID-19 which aims to reduce symptoms and prevent progression to severe illness in people who are at higher risk e.g. people with asthma, hypertension, cardiovascular disease or diabetes.
By taking part, you may gain early access to potential new treatment options, receive regular health checks, and contribute to medical research that could benefit thousands of people in the future.
Description
What to expect
Study details
Ages
18 years or older
Duration
Up to approximately 1 month
Compensation
Participants will be reimbursed for each clinic visit, and all study-related care and treatment will be provided at no cost.
Eligibility Criteria
You may qualify if you:
- Are 18 years or older
- Have tested positive for COVID-19 within the last 5 days (confirmed through PCR or RAT)
- Are currently experiencing mild to moderate symptoms e.g. stuffy nose, sore throat, shortness of breath, cough, low energy
- Have not received a COVID-19 vaccination within the past 4 months
- Other criteria applies.
This clinical research study has non-inclusion criteria (criteria for non-eligibility to participate in a particular clinical study). A member of our team will check if this study is a good fit for you.
Description
COVID-19 is a contagious respiratory illness that can range from mild symptoms, like a sore throat, fatigue, cough or fever, to severe complications, especially in older adults and those with underlying health conditions. While many people recover quickly, others may experience lasting effects such as shortness of breath, brain fog or fatigue. COVID-19 continues to impact individuals, families, and communities worldwide. For some, it can interrupt daily life, limit independence, and cause emotional or physical distress, especially when symptoms linger, or complications arise.
Current treatments for COVID-19 focus on symptom relief, antiviral medications, and supportive care, especially for those at higher risk. While vaccines have significantly reduced severe illness and death, not everyone responds the same, and the virus continues to evolve. Clinical research plays a vital role in developing better treatments, including antiviral therapies and targeted prevention options for vulnerable populations.
This study is exploring whether a potential new antiviral treatment can target the virus early to reduce symptoms and prevent progression to severe illness in people who are at higher risk.
What to expect
You will be assessed by a member of our clinical team to confirm eligibility. If you qualify, you will be assigned to receive treatment.
Over a period of approximately one month, you will attend several clinic visits and check-ins. These will include health assessments, symptom monitoring, and follow-up tests.
Your safety and wellbeing will be carefully monitored throughout the study by an experienced medical team.
Why join this clinical research study?
- By participating, you will contribute to research and receive study-related care at no cost
- Contribute to research focused on early intervention for high-risk individuals
- Receive personalised care and regular health checks
Your privacy is important. All personal information will be kept strictly confidential.
Register your interest today.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
Momentum Clinical Research AU is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. Our Privacy Policy also contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.